A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 25,924 shares of DGX stock, worth $3.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,924
Previous 27,926 7.17%
Holding current value
$3.55 Million
Previous $3.82 Million 7.04%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$137.09 - $137.09 $274,454 - $274,454
-2,002 Reduced 7.17%
25,924 $3.55 Million
Q2 2024

Jul 19, 2024

SELL
$125.91 - $144.34 $4.02 Million - $4.61 Million
-31,933 Reduced 53.35%
27,926 $3.82 Million
Q1 2024

Apr 22, 2024

BUY
$123.78 - $142.11 $347,450 - $398,902
2,807 Added 4.92%
59,859 $7.97 Million
Q4 2023

Jan 16, 2024

BUY
$120.62 - $141.12 $623,967 - $730,013
5,173 Added 9.97%
57,052 $7.87 Million
Q3 2023

Oct 24, 2023

SELL
$121.86 - $144.92 $62,148 - $73,909
-510 Reduced 0.97%
51,879 $6.32 Million
Q2 2023

Jul 25, 2023

SELL
$130.56 - $146.84 $2.59 Million - $2.91 Million
-19,807 Reduced 27.44%
52,389 $7.36 Million
Q1 2023

Apr 14, 2023

BUY
$131.53 - $155.76 $3.21 Million - $3.81 Million
24,440 Added 51.18%
72,196 $10.2 Million
Q4 2022

Feb 08, 2023

SELL
$123.31 - $157.26 $418,760 - $534,054
-3,396 Reduced 6.64%
47,756 $7.47 Million
Q3 2022

Oct 25, 2022

SELL
$121.77 - $141.1 $157,205 - $182,160
-1,291 Reduced 2.46%
51,152 $6.28 Million
Q2 2022

Aug 12, 2022

SELL
$127.07 - $145.39 $479,689 - $548,847
-3,775 Reduced 6.71%
52,443 $6.97 Million
Q1 2022

May 11, 2022

SELL
$129.09 - $164.35 $1.64 Million - $2.08 Million
-12,670 Reduced 18.39%
56,218 $7.7 Million
Q4 2021

Feb 08, 2022

BUY
$140.36 - $173.01 $421,080 - $519,030
3,000 Added 4.55%
68,888 $11.9 Million
Q3 2021

Nov 02, 2021

BUY
$132.95 - $158.0 $194,106 - $230,680
1,460 Added 2.27%
65,888 $9.58 Million
Q2 2021

Aug 11, 2021

SELL
$126.66 - $141.48 $574,149 - $641,328
-4,533 Reduced 6.57%
64,428 $8.5 Million
Q1 2021

May 14, 2021

BUY
$114.63 - $133.34 $2.09 Million - $2.43 Million
18,195 Added 35.84%
68,961 $8.85 Million
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $1.17 Million - $1.33 Million
10,353 Added 25.62%
50,766 $6.05 Million
Q3 2020

Nov 04, 2020

BUY
$107.05 - $130.01 $163,251 - $198,265
1,525 Added 3.92%
40,413 $4.63 Million
Q2 2020

Jul 17, 2020

BUY
$73.34 - $122.61 $29,115 - $48,676
397 Added 1.03%
38,888 $4.43 Million
Q1 2020

Apr 21, 2020

BUY
$75.14 - $115.68 $797,310 - $1.23 Million
10,611 Added 38.06%
38,491 $3.09 Million
Q4 2019

Feb 12, 2020

BUY
$100.29 - $107.99 $208,101 - $224,079
2,075 Added 8.04%
27,880 $2.98 Million
Q3 2019

Nov 07, 2019

BUY
$97.85 - $107.42 $27,398 - $30,077
280 Added 1.1%
25,805 $2.76 Million
Q2 2019

Aug 06, 2019

BUY
$85.18 - $101.94 $393,701 - $471,166
4,622 Added 22.11%
25,525 $2.6 Million
Q1 2019

May 06, 2019

BUY
$80.68 - $89.92 $578,072 - $644,276
7,165 Added 52.15%
20,903 $1.88 Million
Q4 2018

Feb 11, 2019

SELL
$79.75 - $108.38 $12,999 - $17,665
-163 Reduced 1.17%
13,738 $1.14 Million
Q3 2018

Nov 14, 2018

BUY
$105.42 - $114.99 $144,741 - $157,881
1,373 Added 10.96%
13,901 $1.5 Million
Q2 2018

Jul 30, 2018

SELL
$97.35 - $113.14 $36,506 - $42,427
-375 Reduced 2.91%
12,528 $1.38 Million
Q1 2018

Apr 16, 2018

SELL
$96.42 - $107.88 $303,337 - $339,390
-3,146 Reduced 19.6%
12,903 $1.29 Million
Q4 2017

Feb 09, 2018

BUY
$90.86 - $100.24 $2,453 - $2,706
27 Added 0.17%
16,049 $1.58 Million
Q3 2017

Oct 26, 2017

SELL
$91.96 - $108.35 $69,245 - $81,587
-753 Reduced 4.49%
16,022 $1.5 Million
Q2 2017

Aug 15, 2017

BUY
N/A
16,775
16,775 $1.87 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.